Citation: nasso et al.Emergent conversion to open heart surgery during transcatheter aortic valve implantation: the presence of a rescue team improves outcomes.J clin med.2023 dec 15;12(24):7705.Doi: 10.3390/jcm12247705.Earliest date of publication used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
Literature was reviewed regarding emergent conversion to open heart surgery during transcatheter aortic valve implantation. the study population included 825 patients who were predominantly male with a mean age of 79 years. multiple manufacturer¿s devices were implanted in the study population; 542 patients were implanted with a medtronic corevalve (n=94) or evolut r (448) bioprosthetic valve. deaths occurred in the study population; however, there was no statement establishing a causal or contributory relationship between medtronic product and the deaths. among all patients adverse events included: cardiogenic shock, coronary occlusion, cardiac perforation, cardiac arrest, cardiac tamponade, pericardial effusion, major bleeding or vascular complication, arrhythmia requiring permanent pacemaker implant, stroke, myocardial infarction, unspecified bioprosthetic valve dysfunction, aortic and mitral regurgitation, moderate paravalvular leak, and acute kidney injury. no further information was provided pertaining to medtronic products.
|